'Tumour-on-a-chip' technology offers new direction
Thursday, November 7, 2013 - 10:00
in Physics & Chemistry
A two-year collaboration between the Chan and the Rocheleau labs at the Institute of Biomaterials & Biomedical Engineering (IBBME) has led to the development of a new microfluidics screening platform that can accurately predict the way nanoparticles will behave in a living body.